过敏免疫疗法市场报告，按治疗类型（皮下免疫疗法、舌下免疫疗法）、过敏类型、配销通路和地区划分，2025 年至 2033 年

2024IMARC Group全球过敏免疫疗法市场规模达到 34 亿美元。推动市场发展的因素包括过敏症盛行率不断上升、人们对免疫疗法作为过敏症有效治疗方法的认识不断提高、免疫疗法治疗和技术的重大发展、政府对过敏研究的优惠政策和资金支持、以及定製药物和个人化治疗方法。

过敏免疫疗法，也称为减敏或低敏疗法，是针对对各种食物、药物、蜂毒、草花粉和屋尘螨等过敏原的过敏反应的预防性医疗方法。它透过逐渐增加过敏原的剂量来改变免疫系统的反应。在治疗开始之前，过敏症专家和患者会分析过敏症状的诱发因素，这可能涉及皮肤和血液检查以确认过敏原。过敏免疫疗法有助于减少发炎、提供长期影响、增强免疫耐受性、改变疾病进程并改善患者的生活品质。

近年来，由于各种环境和生活方式因素影响了免疫系统的功能，世界各地过敏症的盛行率上升。随着人们对过敏免疫疗法认识的不断提高、收入水平的提高和医疗保健支出的增加，对复杂和长期治疗方案的需求正在增加，这反过来又刺激了市场的成长。由于世界各国政府和非政府组织采取了多项倡议，临床研究和开发预算的不断增加进一步支持了这项进程。此外，利用最新的药物开发技术，製药公司已经创造出更有效的免疫疗法，可成功治疗多种过敏。这一趋势加上过敏诊断领域的进步，正在催化全球过敏免疫疗法市场的成长。

本报告解答的关键问题

• 2024 年全球过敏免疫疗法市场规模？ 2025-2033 年全球过敏免疫疗法市场的预期成长率是多少？
• 推动全球过敏免疫疗法市场发展的关键因素有哪些？
• COVID-19 对全球过敏免疫疗法市场有何影响？
• 根据治疗类型，全球过敏免疫疗法市场如何分布？
• 根据过敏类型，全球过敏免疫疗法市场如何分布？
• 根据配销通路，全球过敏免疫疗法市场分布如何？
• 全球过敏免疫疗法市场的主要地区有哪些？
• 全球过敏免疫疗法市场的主要参与者/公司有哪些？

目录

第 1 章：前言

第 2 章：范围与方法

• 研究目标
• 利害关係人
• 资料来源
  • 主要来源
  • 次要来源
• 市场预测
  • 自下而上的方法
  • 自上而下的方法
• 预测方法

第 3 章：执行摘要

第 4 章：简介

• 概述
• 主要行业趋势

第 5 章：全球过敏免疫疗法市场

• 市场概况
• 市场表现
• COVID-19 的影响
• 市场区隔：按治疗类型
• 市场区隔：依过敏类型
• 市场区隔：按配销通路
• 市场分布：按地区
• 市场预测

第六章：市场区隔：依治疗类型

• 皮下免疫治疗 (SCIT)
  • 市场趋势
  • 市场预测
• 舌下免疫治疗 (SLIT)
  • 市场趋势
  • 市场预测

第 7 章：市场区隔：依过敏类型

• 过敏性鼻炎
  • 市场趋势
  • 市场预测
• 气喘
  • 市场趋势
  • 市场预测
• 食物过敏
  • 市场趋势
  • 市场预测
• 毒液过敏
  • 市场趋势
  • 市场预测
• 其他的
  • 市场趋势
  • 市场预测

第 8 章：市场区隔：按配销通路

• 医院药房
  • 市场趋势
  • 市场预测
• 零售药局
  • 市场趋势
  • 市场预测
• 网路药局
  • 市场趋势
  • 市场预测

第九章：市场细分：依地区

• 欧洲
  • 市场趋势
  • 市场预测
• 北美洲
  • 市场趋势
  • 市场预测
• 亚太地区
  • 市场趋势
  • 市场预测
• 中东和非洲
  • 市场趋势
  • 市场预测
• 拉丁美洲
  • 市场趋势
  • 市场预测

第 10 章：SWOT 分析

• 概述
• 优势
• 弱点
• 机会
• 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

• 概述
• 买家的议价能力
• 供应商的议价能力
• 竞争程度
• 新进入者的威胁
• 替代品的威胁

第 13 章：价格分析

• 价格指标
• 价格结构
• 利润分析

第 14 章：竞争格局

• 市场结构
• 关键参与者
• 关键参与者简介
  • ALK-Abello A/S
  • Allergy Therapeutics
  • Stallergenes Greer
  • HAL Allergy Holding BV
  • DBV Technologies
  • Merck KGaA
  • Aimmune Therapeutics
  • Circassia Pharmaceuticals
  • Anergis SA
  • Biomay AG

The global allergy immunotherapies market size reached USD 3.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.5 Billion by 2033, exhibiting a growth rate (CAGR) of 8.29% during 2025-2033. The market is propelled by the rising prevalence of allergic conditions, increasing awareness about immunotherapy as an effective treatment for allergies, significant developments in immunotherapy treatments and technologies, favorable government policies and funding for allergy research, and customized medicine and tailored treatment approaches.

Allergy immunotherapy, also known as desensitization or hypo-sensitization, is a preventive medical treatment for allergic reactions to allergens including various foods, drugs, bee venom, grass pollens and house dust mites. It alters the immune system's response by gradually increasing the doses of the allergen. Before the treatment begins, an allergist and patient analyze triggering factors for allergy symptoms, which may involve skin and blood tests to confirm the allergens. Allergy immunotherapy helps in reducing inflammation, offering long-term impact, increasing immunological tolerance, changing the course of the disease and improving the quality of the patient's life.

In recent years, there has been a rise in the prevalence of allergies around the world on account of various environmental and lifestyle factors that influence the functioning of the immune system. With the growing awareness of allergy immunotherapies, elevating income levels and increasing healthcare expenditure, the demand for sophisticated and long-term treatment options is increasing, which in turn is stimulating the growth of the market. It is further supported by the rising clinical research and development budget owing to several initiatives undertaken by both governmental and non-governmental organizations around the world. Further, with the latest drug development technologies, pharmaceutical firms have created more efficient immunotherapies for treating an array of allergies successfully. This, coupled with advancements in the field of allergy diagnostics, is catalyzing the global allergy immunotherapies market growth.

Key Market Segmentation:

Breakup by Treatment Type:

• Subcutaneous Immunotherapy (SCIT)
• Sublingual Immunotherapy (SLIT)

Breakup by Allergy Type:

• Allergic Rhinitis
• Asthma
• Food Allergy
• Venom Allergy
• Others

Breakup by Distribution Channel:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Breakup by Region:

• Europe
• North America
• Asia Pacific
• Middle East and Africa
• Latin America

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being ALK-Abello A/S, Allergy Therapeutics, Stallergenes Greer, HAL Allergy Holding B.V., DBV Technologies, Merck KGaA, Aimmune Therapeutics, Circassia Pharmaceuticals, Anergis SA, and Biomay AG, etc.

Key Questions Answered in This Report

• 1.What was the size of the global allergy immunotherapies market in 2024?
• 2.What is the expected growth rate of the global allergy immunotherapies market during 2025-2033?
• 3.What are the key factors driving the global allergy immunotherapies market?
• 4.What has been the impact of COVID-19 on the global allergy immunotherapies market?
• 5.What is the breakup of the global allergy immunotherapies market based on the treatment type?
• 6.What is the breakup of the global allergy immunotherapies market based on the allergy type?
• 7.What is the breakup of the global allergy immunotherapies market based on the distribution channel?
• 8.What are the key regions in the global allergy immunotherapies market?
• 9.Who are the key players/companies in the global allergy immunotherapies market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Allergy Immunotherapies Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Treatment Type
• 5.5 Market Breakup by Allergy Type
• 5.6 Market Breakup by Distribution Channel
• 5.7 Market Breakup by Region
• 5.8 Market Forecast

6 Market Breakup by Treatment Type

• 6.1 Subcutaneous Immunotherapy (SCIT)
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Sublingual Immunotherapy (SLIT)
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Allergy Type

• 7.1 Allergic Rhinitis
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Asthma
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Food Allergy
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Venom Allergy
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Distribution Channel

• 8.1 Hospital Pharmacy
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Retail Pharmacy
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Online Pharmacy
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 Europe
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 North America
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Asia Pacific
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Middle East and Africa
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast
• 9.5 Latin America
  • 9.5.1 Market Trends
  • 9.5.2 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

• 13.1 Price Indicators
• 13.2 Price Structure
• 13.3 Margin Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 ALK-Abello A/S
  • 14.3.2 Allergy Therapeutics
  • 14.3.3 Stallergenes Greer
  • 14.3.4 HAL Allergy Holding B.V.
  • 14.3.5 DBV Technologies
  • 14.3.6 Merck KGaA
  • 14.3.7 Aimmune Therapeutics
  • 14.3.8 Circassia Pharmaceuticals
  • 14.3.9 Anergis SA
  • 14.3.10 Biomay AG

List of Figures

• Figure 1: Global: Allergy Immunotherapies Market: Major Drivers and Challenges
• Figure 2: Global: Allergy Immunotherapies Market: Sales Value (in Billion USD), 2019-2024
• Figure 3: Global: Allergy Immunotherapies Market: Breakup by Treatment Type (in %), 2024
• Figure 4: Global: Allergy Immunotherapies Market: Breakup by Allergy Type (in %), 2024
• Figure 5: Global: Allergy Immunotherapies Market: Breakup by Distribution Channel (in %), 2024
• Figure 6: Global: Allergy Immunotherapies Market: Breakup by Region (in %), 2024
• Figure 7: Global: Allergy Immunotherapies Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 8: Global: Allergy Immunotherapies Industry: SWOT Analysis
• Figure 9: Global: Allergy Immunotherapies Industry: Value Chain Analysis
• Figure 10: Global: Allergy Immunotherapies Industry: Porter's Five Forces Analysis
• Figure 11: Global: Allergy Immunotherapies (Subcutaneous Immunotherapy) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 12: Global: Allergy Immunotherapies (Subcutaneous Immunotherapy) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 13: Global: Allergy Immunotherapies (Sublingual Immunotherapy) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 14: Global: Allergy Immunotherapies (Sublingual Immunotherapy) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 15: Global: Allergy Immunotherapies (Allergic Rhinitis) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 16: Global: Allergy Immunotherapies (Allergic Rhinitis) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 17: Global: Allergy Immunotherapies (Asthma) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 18: Global: Allergy Immunotherapies (Asthma) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 19: Global: Allergy Immunotherapies (Food Allergy) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 20: Global: Allergy Immunotherapies (Food Allergy) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 21: Global: Allergy Immunotherapies (Venom Allergy) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 22: Global: Allergy Immunotherapies (Venom Allergy) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 23: Global: Allergy Immunotherapies (Other Allergy Types) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 24: Global: Allergy Immunotherapies (Other Allergy Types) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 25: Global: Allergy Immunotherapies Market: Sales through Hospital Pharmacy (in Million USD), 2019 & 2024
• Figure 26: Global: Allergy Immunotherapies Market Forecast: Sales through Hospital Pharmacy (in Million USD), 2025-2033
• Figure 27: Global: Allergy Immunotherapies Market: Sales through Retail Pharmacy (in Million USD), 2019 & 2024
• Figure 28: Global: Allergy Immunotherapies Market Forecast: Sales through Retail Pharmacy (in Million USD), 2025-2033
• Figure 29: Global: Allergy Immunotherapies Market: Online Sales (in Million USD), 2019 & 2024
• Figure 30: Global: Allergy Immunotherapies Market Forecast: Online Sales (in Million USD), 2025-2033
• Figure 31: Europe: Allergy Immunotherapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 32: Europe: Allergy Immunotherapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 33: North America: Allergy Immunotherapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 34: North America: Allergy Immunotherapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 35: Asia Pacific: Allergy Immunotherapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 36: Asia Pacific: Allergy Immunotherapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 37: Middle East and Africa: Allergy Immunotherapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 38: Middle East and Africa: Allergy Immunotherapies Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 39: Latin America: Allergy Immunotherapies Market: Sales Value (in Million USD), 2019 & 2024
• Figure 40: Latin America: Allergy Immunotherapies Market Forecast: Sales Value (in Million USD), 2025-2033

List of Tables

• Table 1: Global: Allergy Immunotherapies Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Allergy Immunotherapies Market Forecast: Breakup by Treatment Type (in Million USD), 2025-2033
• Table 3: Global: Allergy Immunotherapies Market Forecast: Breakup by Allergy Type (in Million USD), 2025-2033
• Table 4: Global: Allergy Immunotherapies Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
• Table 5: Global: Allergy Immunotherapies Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 6: Global: Allergy Immunotherapies Market Structure
• Table 7: Global: Allergy Immunotherapies Market: Key Players